You have 9 free searches left this month | for more free features.

APBSCT

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)

Active, not recruiting
  • Graft Versus Host Disease
  • +2 more
  • rituximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

Not yet recruiting
  • Granulocyte Colony-stimulating Factor
  • Stem Cell Mobilization
  • (no location specified)
Jun 13, 2022

Myeloma, Transplant-eligible Patients Trial in Lebanon (Ex-vivo expanded effector cells)

Completed
  • Myeloma
  • Transplant-eligible Patients
  • Ex-vivo expanded effector cells
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Mar 1, 2019

Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

Completed
  • Lymphoma
  • rituximab
  • +10 more
  • Portland, Oregon
  • +14 more
Jan 29, 2021

Lymphoma Trial (high-dose etoposide)

Completed
  • Lymphoma
  • high-dose etoposide
  • (no location specified)
Apr 26, 2017

CNS Lymphoma Trial in Worldwide (drug, radiation, other)

Completed
  • Central Nervous System Lymphoma
  • Aachen, Germany
  • +22 more
Aug 22, 2017

Non-Hodgkin's Lymphoma, Hodgkins Disease Trial in United States (Fludarabine, Busulfan, Anti-Thymocyte Globulin)

Completed
  • Non-Hodgkin's Lymphoma
  • Hodgkins Disease
  • Chicago, Illinois
  • +5 more
Mar 4, 2019

Higher Infused Lymphocyte Counts Improve Antibody Response to

Completed
  • Lymphoma
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    May 18, 2018

    Non-Hodgkin's Lymphoma, Hodgkin's Disease, Multiple Myeloma Trial in Lebanon (GM-CSF, IL-2)

    Completed
    • Non-Hodgkin's Lymphoma
    • +4 more
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Apr 23, 2018

    Multiple Myeloma Trial in Houston (Melphalan, Fludarabine, Stem Cell Infusion)

    Completed
    • Multiple Myeloma
    • Houston, Texas
      UT MD . Anderson Cancer Center
    Oct 3, 2014

    Non Hodgkin's Lymphoma Trial in Indianapolis (clofarabine)

    Completed
    • Non Hodgkin's Lymphoma
    • Indianapolis, Indiana
      Indiana University Cancer Center
    Sep 10, 2014

    Lymphoma Trial in Omaha (drug, procedure, radiation)

    Completed
    • Lymphoma
    • Omaha, Nebraska
      UNMC Eppley Cancer Center at the University of Nebraska Medical
    May 26, 2015

    Lymphoma Trial in Ireland, United Kingdom (biological, drug, procedure, radiation)

    Unknown status
    • Lymphoma
    • bleomycin sulfate
    • +13 more
    • Dublin, Ireland
    • +20 more
    Aug 6, 2013

    Lymphoma Trial in Belgium, Netherlands (biological, drug, procedure, radiation)

    Completed
    • Lymphoma
    • filgrastim
    • +12 more
    • Leuven, Belgium
    • +16 more
    Aug 9, 2013

    Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Tumor Trial in Little Rock, Bethesda (autologous

    Completed
    • Stage II Multiple Myeloma
    • +2 more
    • autologous tumor cell vaccine
    • +3 more
    • Little Rock, Arkansas
    • +2 more
    Jun 19, 2013

    Leukemia, Lymphoma Trial in Chicago (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • Lymphoma
    • filgrastim
    • +4 more
    • Chicago, Illinois
      Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
    Jun 8, 2012

    Non-Hodgkin's Lymphoma Trial in Magdeburg (Rituximab, DHAP, TEC)

    Unknown status
    • Non-Hodgkin's Lymphoma
    • Magdeburg, Germany
      University of Magdeburg
    Oct 5, 2006